HIV/AIDS Research
Canadian study to address barriers to HIV and hepatitis care among drug users
Published in Hepatitis Weekly, May 22nd, 2006
The five-year study is funded by a grant from the Canadian Institutes of Health Research. The funding announcement follows a recent grant from the U.S. Department of Health to monitor the rise of drug-resistant HIV among users of crystal methamphetamine in Vancouver's Downtown Eastside.
In B.C., all anti-HIV medications are distributed at no cost to eligible HIV-infected individuals through the Center's Drug Treatment Program. In 2003, the Centre...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-05-22)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Hepatitis B and delta virus share common hepatocyte entry step - Hepatitis C Therapy
Hepatitis C virus replication is inhibited by cyclosporin DEBIO-025 in vitro - Hepatitis C Therapy
Hepatitis C virus-induced inhibition of interferon signaling can be corrected - Hepatitis C Virus
HCV core protein enhances the immunogenicity of co-delivered DNA vaccine - Hepatitis C Virus
Hepatitis C virus RNA-dependent RNA polymerase inhibitors identified - Autoimmune Hepatitis
Autoimmune hepatitis development is influenced by genetic background - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
